How Genetic & Biomarker Testing Can Help Guide Your Care
Genetic (germline) and biomarker (tumor) testing are two separate types of testing that can help you and your doctor learn as much as possible about your specific prostate cancer. The results can inform your prognosis, treatment options, clinical trial eligibility, and family cancer risk.
PCF Chief Medical Officer Dr. Phillip J. Koo leads a discussion of who should consider testing, when testing is used across the prostate cancer journey, and what it can mean for your care.
Learn how to advocate for yourself and what questions to ask your healthcare provider.
Speakers:
- Andrew Hahn, MD (MD Anderson), medical oncologist
- Brian Helfand, MD, PhD (Endeavor Health Medical Group), urologic oncologist
- Justin Lorentz, MSc (University of Toronto), genetic counselor
PCF thanks Pfizer for their support of this webinar.
